LC-ID-MS/MS (Analytical method)

Go to Analytical method classification
ID107
NameLC-ID-MS/MS
ClassificationAnalytical methods > Chromatography > Liquid chromatography (LC)

Publications with LC-ID-MS/MS

TitleFirst authorYear
Urinary phthalate metabolites and their biotransformation products: predictors and temporal variability among men and womenMeeker2012
Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort studyKim2014
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyRejnmark2009
Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and GliomaZigmont2015
Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention StudyGuertin2017
Plasma phytoestrogens concentration and risk of colorectal cancer in two different Asian populationsKo2018
Plasma enterolactone and breast cancer risk in the Nurses' Health Study IIXie2013
Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control studyKuijsten2008
Plasma phytoestrogens and subsequent breast cancer riskVerheus2007
Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer riskLow2006
Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populationsvan Duijnhoven2018

Biomarker data

Measurements of biomarkers by LC-ID-MS/MS

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured by LC-ID-MS/MS and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured by LC-ID-MS/MS and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication